QQQ   431.97 (+0.21%)
AAPL   169.76 (-1.70%)
MSFT   416.30 (+0.64%)
META   503.30 (+0.61%)
GOOGL   154.79 (-0.05%)
AMZN   184.08 (+0.25%)
TSLA   157.09 (-2.72%)
NVDA   871.25 (+1.31%)
AMD   163.25 (+1.83%)
NIO   3.81 (-2.06%)
BABA   69.79 (-1.18%)
T   16.07 (-1.05%)
F   12.17 (-0.49%)
MU   121.21 (-0.13%)
GE   155.45 (+1.14%)
CGC   6.96 (-0.29%)
DIS   114.27 (+1.17%)
AMC   2.74 (+10.93%)
PFE   25.86 (-0.19%)
PYPL   64.03 (+0.82%)
XOM   118.84 (-0.70%)
QQQ   431.97 (+0.21%)
AAPL   169.76 (-1.70%)
MSFT   416.30 (+0.64%)
META   503.30 (+0.61%)
GOOGL   154.79 (-0.05%)
AMZN   184.08 (+0.25%)
TSLA   157.09 (-2.72%)
NVDA   871.25 (+1.31%)
AMD   163.25 (+1.83%)
NIO   3.81 (-2.06%)
BABA   69.79 (-1.18%)
T   16.07 (-1.05%)
F   12.17 (-0.49%)
MU   121.21 (-0.13%)
GE   155.45 (+1.14%)
CGC   6.96 (-0.29%)
DIS   114.27 (+1.17%)
AMC   2.74 (+10.93%)
PFE   25.86 (-0.19%)
PYPL   64.03 (+0.82%)
XOM   118.84 (-0.70%)
QQQ   431.97 (+0.21%)
AAPL   169.76 (-1.70%)
MSFT   416.30 (+0.64%)
META   503.30 (+0.61%)
GOOGL   154.79 (-0.05%)
AMZN   184.08 (+0.25%)
TSLA   157.09 (-2.72%)
NVDA   871.25 (+1.31%)
AMD   163.25 (+1.83%)
NIO   3.81 (-2.06%)
BABA   69.79 (-1.18%)
T   16.07 (-1.05%)
F   12.17 (-0.49%)
MU   121.21 (-0.13%)
GE   155.45 (+1.14%)
CGC   6.96 (-0.29%)
DIS   114.27 (+1.17%)
AMC   2.74 (+10.93%)
PFE   25.86 (-0.19%)
PYPL   64.03 (+0.82%)
XOM   118.84 (-0.70%)
QQQ   431.97 (+0.21%)
AAPL   169.76 (-1.70%)
MSFT   416.30 (+0.64%)
META   503.30 (+0.61%)
GOOGL   154.79 (-0.05%)
AMZN   184.08 (+0.25%)
TSLA   157.09 (-2.72%)
NVDA   871.25 (+1.31%)
AMD   163.25 (+1.83%)
NIO   3.81 (-2.06%)
BABA   69.79 (-1.18%)
T   16.07 (-1.05%)
F   12.17 (-0.49%)
MU   121.21 (-0.13%)
GE   155.45 (+1.14%)
CGC   6.96 (-0.29%)
DIS   114.27 (+1.17%)
AMC   2.74 (+10.93%)
PFE   25.86 (-0.19%)
PYPL   64.03 (+0.82%)
XOM   118.84 (-0.70%)

Cellectar Biosciences (CLRB) Earnings Date, Estimates & Call Transcripts

$3.30
-0.02 (-0.60%)
(As of 12:32 PM ET)
Skip Charts & View Estimated and Actual Earnings Data

CLRB Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CLRB Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Cellectar Biosciences Analyst EPS Estimates

Current Year EPS Consensus Estimate:($1.85) EPS
Next Year EPS Consensus Estimate: ($0.58) EPS

CLRB Earnings Date and Information

Cellectar Biosciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 2nd, 2024 based off prior year's report dates.

Cellectar Biosciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/2/2024
Estimated)
------- 
11/13/2023Q3 2023($0.44)($0.82)($0.38)($0.43)--
8/14/2023Q2 2023($0.69)($0.73)($0.04)($0.73)--
5/4/2023Q1 2023($0.75)($0.76)($0.01)($0.76)--
3/9/2023Q4 2022($0.83)($0.55)+$0.28($0.55)--
11/3/2022Q3 2022($1.21)($1.28)($0.07)($1.28)--
8/5/2022Q2 2022($1.08)($1.22)($0.14)($1.22)--
5/10/2022Q1 2022($1.10)($1.00)+$0.10($0.10)--    
3/21/2022Q4 2021($1.00)($1.00)-($0.10)--
11/7/2021Q3 2021($1.10)($1.00)+$0.10($0.10)--
8/8/2021Q2 2021($1.10)($1.10)-($0.11)--
5/9/2021Q1 2021($1.00)($1.30)($0.30)($0.13)--

Cellectar Biosciences Earnings - Frequently Asked Questions

When is Cellectar Biosciences's earnings date?

Cellectar Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 2nd, 2024 based off last year's report dates. Learn more on CLRB's earnings history.

How much profit does Cellectar Biosciences generate each year?

Cellectar Biosciences (NASDAQ:CLRB) has a recorded net income of -$37.98 million. CLRB has generated -$3.10 earnings per share over the last four quarters.

What is Cellectar Biosciences's EPS forecast for next year?

Cellectar Biosciences's earnings are expected to grow from ($1.85) per share to ($0.58) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:CLRB) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners